You are viewing: Brazil Compounding Pharmacy Market analysis
Part of: Compounding Pharmacy Market (Global)

The Brazil Compounding Pharmacy Market was valued at $129.3 Million in 2025 and projected to reach to $159.2 Million by 2030, representing a compound annual growth rate of 4.3%. Brazil's compounding pharmacy market is poised for steady growth through 2030, supported by increasing healthcare awareness and rising disposable incomes among Brazilian consumers.

Brazil Compounding Pharmacy Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Brazil Compounding Pharmacy Market Trends and Insights

  • Brazil represents a significant opportunity within Latin America's healthcare sector, driven by increasing demand for personalized pharmaceutical solutions and rising healthcare expenditure.
  • The market in Brazil is supported by a growing population seeking customized medications and a regulatory environment that continues to recognize the importance of compounding services. The compounding pharmacy sector in Brazil is experiencing steady expansion as healthcare providers and patients increasingly recognize the benefits of tailored pharmaceutical formulations.
  • Brazil's market growth is underpinned by factors including improved access to compounding services in urban centers, rising chronic disease prevalence, and greater awareness among healthcare professionals.
  • Between 2025 and 2030, Brazil is expected to maintain consistent market momentum, with the sector benefiting from demographic shifts and evolving patient preferences for personalized medicine. Brazil's compounding pharmacy market reflects broader trends in Latin America toward specialized healthcare services.
  • The country's market trajectory demonstrates resilience and opportunity, positioning Brazil as a key growth market for compounding pharmacy providers and stakeholders seeking to expand their presence in the region..

Key Market Statistics

  • CAGR (2025-2030) 4.3% CAGR
  • Market Size, 2025 ~USD 129.3 Million
  • Forecast, 2030 ~USD 159.2 Million
  • Country Brazil

Brazil Compounding Pharmacy Market Overview

Market Valuation :

Brazil's compounding pharmacy market is valued at USD 129.3 million in 2025, with projections reaching USD 159.2 million by 2030, representing significant growth potential in Latin America's largest economy.

Growth Trajectory :

The Brazilian market is expanding at a CAGR of 4.3% through 2030, driven by increasing adoption of personalized pharmaceutical solutions and growing healthcare expenditure across the country.

Healthcare Demand Drivers :

Rising consumer preference for customized medications, improved healthcare accessibility in urban centers, and expanding middle-class demographics are fueling demand for compounding pharmacy services in Brazil.

Regional Significance :

Brazil represents a critical market opportunity within Latin America's healthcare sector, positioning it as a key investment destination for pharmaceutical and healthcare service providers.

Brazil Compounding Pharmacy Market Dynamics

  • The market benefits from a growing preference for personalized medication solutions tailored to individual patient needs, particularly in urban areas like São Paulo and Rio de Janeiro.
  • Regulatory improvements and enhanced pharmaceutical distribution networks are expected to facilitate market expansion. Key growth catalysts include expanding private healthcare insurance coverage, rising prevalence of chronic diseases requiring customized treatments, and growing adoption of compounding services among healthcare professionals.
  • The market's 4.3% CAGR reflects Brazil's developing healthcare infrastructure and increasing investment in pharmaceutical innovation, positioning the country as an attractive market for compounding pharmacy operators and suppliers..

Market Ecosystem

logo-mobile

COMPOUNDING PHARMACY MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
company logo
Provides sterile and non-sterile compounding services, including ready-to-dispense and ready-to-administer personalized medicines for pharmacies, hospitals, and clinics | Its compounding operations support customized strengths, dosage forms, ingredient requirements, and therapies where commercially available medicines may be unsuitable or unavailable. Enables healthcare providers to address patient-specific medication requirements, drug shortages, discontinued products, allergies, and dosage-form limitations while outsourcing complex sterile and non-sterile compounding activities.
company logo
Operates both a 503A compounding pharmacy for patient-specific prescriptions and an FDA-registered 503B outsourcing facility for office-use medications | Its portfolio includes compounded preparations across multiple therapeutic areas and dosage forms, supported by sterile batch testing and cGMP processes at the 503B facility. Expands access to individualized medicines and multiple strengths and dosage forms while enabling healthcare providers to procure larger-scale compounded products from a regulated outsourcing facility.

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

Related Ecosystem

Pharmaceuticals

Top Technologies
  • Bioreactors
  • Analytical Testing
  • Bioanalytical Testing Services
  • Cell Counters
  • Data Management Services
Top Companies
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • SANOFI
  • Pfizer Inc.
  • NOVARTIS

    Key Takeaways

    • Brazil's compounding pharmacy market is valued at USD 129.3 million in 2025 and is forecast to reach USD 159.2 million by 2030.
    • Brazil is experiencing a 4.3% CAGR, reflecting steady growth driven by personalized medicine demand and healthcare modernization.
    • Brazil's market expansion is supported by rising chronic disease prevalence and increased healthcare professional awareness of compounding benefits.
    • Brazil represents a key growth opportunity within Latin America, with favorable demographics and evolving regulatory recognition of compounding services.

    Compounding Pharmacy Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment HORMONE REPLACEMENT THERAPIES (Therapeutic Application)
    Forecast Period 2025–2030
    Growth Rate CAGR of 5.7% from 2025 to 2030
    Largest Segment PHARMACEUTICAL DOSAGE ALTERATION (Compounding Type)
    Market Size Base Year (Billions) ~USD 14.71 (2025)
    Revenue Forecast (Billions) ~USD 19.41 (2030)
    Segments Covered Product, Compounding Type, Therapeutic Application

    Brazil Compounding Pharmacy Market Report Segmentation

    3 segment dimensions are covered across the global market.

    By Product

    • Nasal Drugs
    • Ophthalmic Drugs
    • Oral Drugs
    • Other Products
    • Parenteral Drugs
    • Rectal Drugs
    • Topical Drugs

    By Compounding Type

    • Currently Unavailable Pharmaceutical Manufacturing
    • Pharmaceutical Dosage Alteration
    • Pharmaceutical Ingredient Alteration

    By Therapeutic Application

    • Dermal Disorders
    • Hormone Replacement Therapies
    • Nutritional Supplements
    • Other Therapeutic Applications
    • Pain Management

    BRAZIL: COMPOUNDING PHARMACY MARKET, BY END USER, 2023–2030

    Segment20232024202520262027202820292030CAGR (%)
    ADULTS186.8205.2220.8233.6243.6251.7260.2269.94.1
    GERIATRIC PATIENTS83.190.696.8101.7105.3108110.8114.13.3
    PEDIATRIC PATIENTS55.962.368.173.177.481.185.189.55.6
    TOTAL325.7358.1385.6408.3426.3440.8456.1473.54.2

    Target Audience

    • Pharmaceutical Companies : Pharmaceutical manufacturers and distributors need Brazil-specific market data to assess expansion opportunities, develop localized product strategies, and understand demand for compounding services.
    • Healthcare Investors : Investment firms and private equity groups require detailed market analysis of Brazil's compounding pharmacy sector to evaluate investment returns, growth potential, and risk factors in the region.
    • Compounding Pharmacy Operators : Existing and prospective compounding pharmacy owners need market insights to optimize operations, identify growth markets within Brazil, and understand competitive positioning and customer demand.
    • Healthcare Consultants : Management consultants and healthcare advisors require Brazil market data to provide strategic recommendations to clients, support business planning, and identify market opportunities.
    • Market Researchers & Analysts : Research professionals and industry analysts need comprehensive Brazil compounding pharmacy data to support market reports, competitive analysis, and strategic forecasting for healthcare stakeholders.

    Key Companies in the Brazil Compounding Pharmacy Market

    CompanyHQOwnershipStrongest segments
    BAXTERUnited StatesPublic CompanyMedical Products & Therapies (IV, infusion, parenteral nutrition, renal-related therapies),Healthcare Systems & Technologies (smart beds, monitoring, OR integration, surgical equipment),Pharmaceuticals (generic and specialty injectables, inhaled anesthetics, compounding services),
    FAGRONBelgiumPublic CompanyEssentials (APIs, excipients, bases),Brands (derma, immunology, hair, scar care),Compounding Services,

    BAXTER

    Baxter is a publicly traded American healthcare company founded in 1931 that employs 37,500 people. The company operates as a major medical device and pharmaceutical manufacturer serving global markets.

    FAGRON

    Fagron is a publicly traded Belgian pharmaceutical company founded in 1990 with 4,880 employees. The company focuses on pharmaceutical compounding and specialty pharmacy solutions.

    Reasons to Buy this Report

    • Market Entry Strategy : Gain comprehensive insights into Brazil's compounding pharmacy landscape to develop targeted market entry strategies and identify high-potential regions for expansion within Latin America's largest healthcare market.
    • Competitive Intelligence : Understand competitive dynamics, market positioning, and key players operating in Brazil's compounding pharmacy sector to benchmark performance and identify differentiation opportunities.
    • Investment Decision Support : Access detailed market valuation data and growth projections through 2030 to support investment decisions, business planning, and resource allocation in Brazil's pharmaceutical sector.
    • Regulatory & Operational Insights : Obtain country-specific information on regulatory requirements, healthcare infrastructure, and operational considerations essential for successful compounding pharmacy operations in Brazil.
    • Growth Opportunity Identification : Identify emerging trends, demand drivers, and untapped market segments within Brazil's compounding pharmacy sector to capitalize on the 4.3% CAGR growth through 2030.

    Frequently asked questions

    What is the current size of Brazil's compounding pharmacy market?

    Brazil's compounding pharmacy market is valued at USD 129.3 million in 2025.

    What is the projected market size for Brazil's compounding pharmacy sector by 2030?

    Brazil's compounding pharmacy market is projected to reach USD 159.2 million by 2030.

    What is the growth rate of Brazil's compounding pharmacy market?

    Brazil's compounding pharmacy market is growing at a CAGR of 4.3% from 2025 to 2030.

    What factors are driving growth in Brazil's compounding pharmacy market?

    Growth in Brazil is driven by increasing demand for personalized medications, rising chronic disease prevalence, improved access to compounding services, and greater healthcare professional awareness.

    How does Brazil's compounding pharmacy market compare to other Latin American countries?

    Brazil represents a significant portion of the Latin American compounding pharmacy market, with steady growth reflecting the country's large population, healthcare modernization, and favorable regulatory environment.

    RESEARCH METHODOLOGY

    This study involved four major activities to estimate the current size of the compounding pharmacy market. We conducted exhaustive secondary research to gather information on the market, its peer markets, and its parent market. The team then validated these findings, assumptions, and sizing with industry experts across the value chain through primary research. We used both top-down and bottom-up approaches to estimate total market size. We then used data triangulation to estimate market size by segment and subsegment.

    Secondary Research

    Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the compounding pharmacy market. The secondary sources used for this study include US Food and Drug Administration (FDA), American Pharmacists Association (APhA), International Academy of Compounding Pharmacists (IACP), National Community Pharmacists Association (NCPA), Parenteral Drug Association (PDA), American Society of Health-System Pharmacists (ASHP), Pharmacy Compounding Accreditation Board (PCAB), European Directorate for the Quality of Medicines & HealthCare (EDQM), European Medicines Agency (EMA), International Pharmaceutical Federation (FIP), Journal of Compounding & Specialty Pharmacy (JCSP), National Center for Biotechnology Information (NCBI), Pharmaceutical Research and Manufacturers of America (PhRMA), Pharma & Biopharma Outsourcing Association (PBOA), and World Journal of Pharmaceutical Research (WJPR). Secondary sources also include corporate and regulatory filings, such as annual reports, SEC filings, investor presentations, and financial statements; business magazines & research journals; press releases; trade, business, and professional associations; and MarketsandMarkets Analysis. These sources were also used to obtain key information on major players, market classification, and segmentation based on industry trends, regional/country-level markets, market developments, and technology perspectives.

    Primary Research

    We conducted in-depth interviews with primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among others, to obtain and verify critical qualitative and quantitative information and assess market prospects. We interviewed primary sources from both the supply and demand sides of the market to gather qualitative and quantitative data. The following is a breakdown of the primary respondents:

    Compounding Pharmacy Market Size, and Share

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    We estimated the global size of the compounding pharmacy market using multiple approaches. We used a detailed market estimation approach to estimate and validate the market value and other dependent submarkets. We also used these methods extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following.

    Compounding Pharmacy Market: Top-Down and Bottom-Up Approach

    Compounding Pharmacy Market Top Down and Bottom Up Approach

    Data Triangulation

    After estimating the market size using the process described above, we divided the total market into several segments and subsegments. To complete the overall market analysis and obtain precise statistics for all segments and subsegments, we used data triangulation and market breakdown methods where applicable. We triangulated the data by examining factors and trends from both the demand and supply sides.

    Market Definition

    A compounding pharmacy is a specialized practice in which a licensed pharmacist combines, mixes, or alters raw drug ingredients to formulate customized medications tailored to individual patients' unique health needs. This process allows pharmacists to create pharmaceutical products in various forms, such as liquids, creams, gels, or capsules, and can be vital for patients with specific allergies, intolerances, or those needing dosages not commercially available. Compounding pharmacists often work closely with healthcare providers to develop formulas that address particular medical conditions, ensuring that each preparation is safe, effective, and personalized to optimize patient care. Additionally, compounding pharmacies adhere to stringent regulatory standards to maintain the integrity and quality of the medications they produce.

    Key Stakeholders

    • Pharmaceutical & Biotechnology Companies
    • Compounding Pharmacies
    • Research & Consulting Firms
    • Academic Medical Centers
    • Government Regulatory & Research Organizations
    • Quality Assurance & Accreditation Bodies
    • Clinical Research Institutes

    Report Objectives

    • To define, describe, and forecast the compounding pharmacy market based on product, compounding type, therapeutic application, sterility, end user, and region
    • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall compounding pharmacy market
    • To analyze opportunities for stakeholders and provide details of the competitive landscape for market leaders
    • To forecast the size of the market segments with respect to five regions: North America (US and Canada), Europe (Germany, France, the UK, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific), Latin America (Brazil, Mexico, Argentina, and the Rest of Latin America), and the Middle East & Africa (GCC Countries and the Rest of Middle East & Africa)
    • To profile the key players and analyze their market share and core competencies
    • To analyze competitive developments, such as product launches, partnerships, agreements, collaborations, and expansions
    • To benchmark players within the market using the proprietary “Company Evaluation Matrix” framework, which analyzes market players on various parameters within the broad categories of business and product excellence strategy

    Available customizations:

    With the given market data, MarketsandMarkets offers customization as per the company’s specific needs. The following options are available for the report:

    Geographical Analysis

    • A further breakdown of the Rest of Asia Pacific compounding pharmacy market into countries
    • A further breakdown of the Rest of Europe compounding pharmacy market into countries
    • A further breakdown of the Rest of Latin America compounding pharmacy market into countries

    Company Information

    • Detailed analysis and profiling of additional market players (up to five).
     

     

    Get the Full Compounding Pharmacy Market Report

    Full forecast, segment splits, and company analysis for all Compounding Pharmacy Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status